Clinical trials

  • Ruxolitinib for Thalassemia | Chronic graft versus host disease | Acute graft versus host disease | Chronic graft versus host disease in skin | Chronic graft versus host disease in liver | Chronic graft versus host disease in intestine | Acute graft versus host disease in skin | Acute graft versus host disease in liver | Acute graft versus host disease in intestine | Post essential thrombocythaemia myelofibrosis | Post essential thrombocythemia myelofibrosis | Post polycythaemia vera myelofibrosis | Polycythaemia vera
  • AUTOLOGOUS T-CELLS TRANSDUCED WITH THE LENTIVIRAL LV-R11KEA ENCODING T-CELL RECEPTOR TARGETING PATIENT-SPECIFIC TUMOR-ASSOCIATED ANTIGENS for Solid tumors
  • IANALUMAB for Lupus nephritis
  • COLLAGENASE for Dupuytren's contracture
  • Atorvastatin for Metastatic breast cancer | Metastatic ovarian cancer | Metastatic prostate cancer | Metastatic kidney cancer
  • TRANEXAMIC ACID for Placenta previa | Postpartum hemorrhage
  • AZTREONAM for Detrusor overactivity | Multiple sclerosis | Spinal cord injury
  • FILGRASTIM for Toxic epidermal necrolysis (Lyell syndrome) | Stevens-Johnson syndrome
  • VERAPAMIL for Type 1 diabetes
  • Colecalciferol (cholecalciferol) for Allergic rhinitis
  • AZACITIDINE, CEDAZURIDINE for Myelodysplastic syndrome | Chronic myelomonocytic leukaemia | Acute myeloid leukaemia
  • VENETOCLAX for Acute myeloid leukemia